298 related articles for article (PubMed ID: 18764859)
1. Off-label use of biologicals in the management of inflammatory oral mucosal disease.
O'Neill ID
J Oral Pathol Med; 2008 Nov; 37(10):575-81. PubMed ID: 18764859
[TBL] [Abstract][Full Text] [Related]
2. Biologic agents and oral diseases -- an update on clinical applications.
Georgakopoulou EA; Andreadis D; Arvanitidis E; Loumou P
Acta Dermatovenerol Croat; 2013; 21(1):24-34. PubMed ID: 23683483
[TBL] [Abstract][Full Text] [Related]
3. Off-label uses of biologic agents in dermatology: a 2006 update.
Kerns MJ; Graves JE; Smith DI; Heffernan MP
Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
[TBL] [Abstract][Full Text] [Related]
4. Infliximab in a patient with refractory mucosal aphthosis.
Jacobi A; Debus D; Schuler G; Hertl M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):109-10. PubMed ID: 18181985
[No Abstract] [Full Text] [Related]
5. Inflammatory diseases of the mucous membranes. Part 2. Immunopathologic ulcerative and desquamative diseases.
Eversole LR
J Calif Dent Assoc; 1994 Apr; 22(4):59-60, 64, 6809 passim. PubMed ID: 8598527
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
7. Biologics in oral medicine: ulcerative disorders.
O'Neill ID; Scully C
Oral Dis; 2013 Jan; 19(1):37-45. PubMed ID: 22471882
[TBL] [Abstract][Full Text] [Related]
8. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
Sobell JM; Kalb RE; Weinberg JM
J Drugs Dermatol; 2009 Feb; 8(2):147-54. PubMed ID: 19213230
[TBL] [Abstract][Full Text] [Related]
9. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of mucous membrane pemphigoid with infliximab.
Heffernan MP; Bentley DD
Arch Dermatol; 2006 Oct; 142(10):1268-70. PubMed ID: 17043180
[No Abstract] [Full Text] [Related]
11. [Immunological aspects of various oral diseases. III. Aphthous stomatitis, pemphigus, benign mucomembranous pemphigoid, DLE, lichen planus, desquamative gingivitis, inflammatory intestinal disease with oral manifestations, Sjögren syndrome].
Gombos F; Serpico R; Astarita GP
Arch Stomatol (Napoli); 1985; 26(2):215-30. PubMed ID: 3870081
[No Abstract] [Full Text] [Related]
12. Differential diagnosis of severe recurrent oral ulceration.
Farquharson A; Ajagbe O; Brown RS
Dent Today; 2002 Mar; 21(3):74-9. PubMed ID: 11915223
[No Abstract] [Full Text] [Related]
13. Role of topical drugs in treatment of oral mucosal diseases. A literature review.
Sheikh S; Gupta D; Pallagatti S; Singla I; Gupta R; Goel V
N Y State Dent J; 2013 Nov; 79(6):58-64. PubMed ID: 24600767
[TBL] [Abstract][Full Text] [Related]
14. Strategies for management of commonly encountered oral mucosal disorders.
Siegel MA
J Calif Dent Assoc; 1999 Mar; 27(3):210-2, 215, 218-9 passim. PubMed ID: 10634127
[TBL] [Abstract][Full Text] [Related]
15. Oral mucosal diseases in the office setting--Part II: oral lichen planus, pemphigus vulgaris, and mucosal pemphigoid.
Sciubba JJ
Gen Dent; 2007; 55(5):464-76; quiz 477-8, 488. PubMed ID: 17899727
[TBL] [Abstract][Full Text] [Related]
16. Chronic mucositis: differential diagnosis and therapeutic management.
Vincent SD
Compendium; 1992 Jul; 13(7):600, 602, 604-10. PubMed ID: 1521296
[No Abstract] [Full Text] [Related]
17. The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis.
Mumcu G; Hayran O; Ozalp DO; Inanc N; Yavuz S; Ergun T; Direskeneli H
J Oral Pathol Med; 2007 Mar; 36(3):147-52. PubMed ID: 17305636
[TBL] [Abstract][Full Text] [Related]
18. Biologics, an alternative therapeutic approach for oral lichen planus.
Zhang J; Zhou G; Du GF; Xu XY; Zhou HM
J Oral Pathol Med; 2011 Aug; 40(7):521-4. PubMed ID: 21463368
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.
Olivieri I; Latanza L; Siringo S; Peruz G; Di Iorio V
J Rheumatol; 2008 May; 35(5):930-2. PubMed ID: 18464316
[TBL] [Abstract][Full Text] [Related]
20. Desquamative gingivitis.
Carson-Mann LD
Probe; 1996; 30(1):36-7. PubMed ID: 9611444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
